Retatrutide holds no UK marketing authorisation and may only be supplied on a named-patient basis via the MHRA 'Specials' framework, where a registered prescriber takes personal responsibility for its use
Clinical Update 3/16/2026 GLP 1 With B-12
Amid the challenges of obesity and its related health concerns, Retatrutide offers a beacon of hope, backed by science and poised to usher in a new era of healthcare transformation
However, like any medication, they may not be suitable for everyone
Postiglione A, Soricelli A, Cicerano U, et al
Semaglutide and Tirzepatide work by targeting multiple pathways involved in weight regulation, including appetite control, insulin regulation, and fat burning